Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions

Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 10

This Paper With 17 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_HPM-7-2_004

تاریخ نمایه سازی: 18 مرداد 1403

Abstract:

Background The measurement of health benefits is a key issue in health economic evaluations. There is very scarce empirical literature exploring the differences of using quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs) as benefit metrics and their potential impact in decision-making.   Methods Two previously published models delivering outputs in QALYs, were adapted to estimate DALYs: a Markov model for human papilloma virus (HPV) vaccination, and a pneumococcal vaccination deterministic model (PNEUMO). Argentina, Chile, and the United Kingdom studies were used, where local EQ-۵D social value weights were available to provide local QALY weights. A primary study with descriptive vignettes was done (n = ۷۳) to obtain EQ-۵D data for all health states included in both models. Several scenario analyses were carried-out to evaluate the relative importance of using different metrics (DALYS or QALYs) to estimate health benefits on these economic evaluations.   Results QALY gains were larger than DALYs avoided in all countries for HPV, leading to more favorable decisions using the former. With discounting and age-weighting – scenario with greatest differences in all countries – incremental DALYs avoided represented the ۷۵%, ۶۸%, and ۴۳% of the QALYs gained in Argentina, Chile, and United Kingdom respectively. Differences using QALYs or DALYs were less consistent and sometimes in the opposite direction for PNEUMO. These differences, similar to other widely used assumptions, could directly influence decision-making using usual gross domestic products (GDPs) per capita per DALY or QALY thresholds.   Conclusion We did not find evidence that contradicts current practice of many researchers and decision-makers of using QALYs or DALYs interchangeably. Differences attributed to the choice of metric could influence final decisions, but similarly to other frequently used assumptions.

Keywords:

Quality-Adjusted Life Year (QALY) , Disability-Adjusted Life Year (DALY) , Health Benefit Measure , Economic Evaluation

Authors

Federico Augustovski

Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina

Lisandro D. Colantonio

University of Alabama at Birmingham, Birmingham, AL, USA

Julieta Galante

Cardiff University, Cardiff, UK

Ariel Bardach

Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina

Joaquín E. Caporale

Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina

Víctor Zárate

Facultad de Medicina, Universidad San Sebastian, Santiago, Chile

Ling Hsiang Chuang

Pharmerit, Rotterdam, The Netherlands

Andres Pichon-Riviere

Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Buenos Aires, Argentina

Paul Kind

University of Leeds, Leeds, UK

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Drummond KF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. ...
  • Debicki D, Ferko N, Demarteau N, et al. Comparison of ...
  • De Wals P, Black S, Borrow R, Pearce D. Modeling ...
  • Marti SG, Colantonio L, Bardach A, et al. A cost-effectiveness ...
  • Colantonio L, Gomez JA, Demarteau N, Standaert B, Pichon-Riviere A, ...
  • Augustovski F, Irazola V, Velazquez A, Gibbons L, Craig B. ...
  • Dolan P. Modeling valuations for EuroQol health states. Medical Care. ...
  • Zarate V, Kind P, Valenzuela P, Vignau A, Olivares-Tirado P, ...
  • Galante J, Augustovski F, Colantonio L, et al. Estimation and ...
  • Primera Encuesta Nacional de Factores de Riesgo. ۱st ed. Buenos ...
  • Health Survey for England. http://www.archive.official-documents.co.uk/document/doh/survey۹۶/tab۵-۲۹.htm. Published ۱۹۹۶ ...
  • Global Burden of Disease ۲۰۰۴ update: disability weights for diseases ...
  • Fox-Rushby JA, Hanson K. Calculating and presenting disability adjusted life ...
  • Murray CJL, Lopez AD. The Global Burden of Disease: A ...
  • Stouthard M, Essink-Bot M, Bonsel G, Barendregt J, Kramers P. ...
  • Salomon JA, Vos T, Hogan DR, et al. Common values ...
  • Sachs JD. Macroeconomics and health: Investing in health for economic ...
  • Principal Global Indicators. International Monetary Fund website. http://www.principalglobalindicators.org/Pages/Default.aspx. Accessed June ...
  • Gandjour A. Drug pricing and control of health expenditures: a ...
  • Hjelmgren J, Berggren F, Andersson F. Health economic guidelinessimilarities, differences ...
  • Augustovski F, Garay OU, Pichon-Riviere A, Rubinstein A, Caporale JE. ...
  • Briggs AH, Weinstein MC, Fenwick EA, et al. Model parameter ...
  • Arnesen T, Kapiriri L. Can the value choices in DALYs ...
  • Arnesen T, Nord E. The value of DALY life: problems ...
  • Dimoliatis ID. Standardised QALYs and DALYs are more understandable, avoid ...
  • Richardson G, Manca A. Calculation of quality adjusted life years ...
  • Zarate V. DALYs and QALYs in developing countries. Health Aff ...
  • Diel R, Lampenius N. Cost-effectiveness analysis of interventions for tuberculosis ...
  • Airoldi M, Morton A. Adjusting life for quality or disability: ...
  • Tan-Torres Edejer T, Baltussen R, Adam T, et al. Making ...
  • نمایش کامل مراجع